Institution statistics

Past rankings:

Ranking timeline:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

^*Ratio includes only projects with > 2 partners

Summary:

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Partners:

Constancy:

Subjects: Diversity index:0.23

Categories:

Project overview:

Start date	Project	acronym	role	funding	partners
2017-09-01	Targeting the metabolism-immune system connections in Cancer	META-CAN	participant	3.831.958	10
2017-09-01	An INtegrated next generation PREParedness programme for improving effective inter-organisational response capacity in complex environments of disasters and causes of crises	IN-PREP	participant	7.999.556	20
2017-06-01	PAN EBOLA VACCINE INNOVATIVE APPROACH	PEVIA	coordinator	6.189.570	13
2017-01-10	Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY	HARMONY	participant	20.200.000	44
2017-01-01	Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)	ALIVER	participant	6.478.738	11
2017-01-01	3-O-sulfated heparan sulfate translocation in altered membrane biology: A newstrategy for early population screening and halting Alzheimer’s neurodegeneration	ArrestAD	participant	3.991.096	8
2017-01-01	REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy	RESPINE	participant	5.555.836	14
2017-01-01	Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection	HIVACAR	participant	6.685.111	14
2017-01-01	SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS	LIVERHOPE	participant	5.998.800	16
2016-10-01	Expanding and extending gene therapy of monogenic diseases of the haematopoietic system	GENE FOR CURE	participant	2.445.268	2
2016-02-01	Decision Support and Information Management System for Breast Cancer	DESIREE	participant	3.340.720	12
2016-01-01	Imaging the Force of Cancer	FORCE	participant	5.812.631	16
2015-11-01	EVA - patient ventilation beyond limits	EVA	participant	1.890.000	4
2015-09-01	REgenerative Stem cell therapy for STroke in Europe	RESSTORE	participant	6.338.259	30
2015-05-01	I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly	I-MOVE-plus	participant	7.482.729	25
2015-05-01	A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly	EU-CaRE	participant	5.593.049	10
2015-05-01	Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension	ENSAT-HT	participant	7.607.337	13
2015-05-01	Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.	CARBALIVE	participant	5.913.080	14
2015-01-01	Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis	ADIPOA2	participant	5.999.000	18
2014-11-01	Prevention and Management of High Threat Pathogen Incidents in Transport Hubs	PANDHUB	participant	3.142.004	6
2014-04-01	Mimimally invasive retrograde targeting of aCAR lentiviral vector to non-human primate motor neurons	RTLVNHP	participant	149.526	2
2014-01-01	Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics	Lab2Go	participant	1.915.000	10
2014-01-01	Tissue engineering of the right heart outflow tract by a biofunctionalized bioresorbable polymeric valved tube	TEH-TUBE	coordinator	4.500.962	7
2013-12-01	A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients	MERCURIC	participant	5.999.995	13
2013-10-01	A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer	GANNET53	participant	5.994.072	18
2013-10-01	Collaborative European NeuroTrauma Effectiveness Research in TBI	CENTER-TBI	participant	29.998.903	38
2013-10-01	Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified.	CFMATTERS	participant	5.999.748	12
2013-09-01	Semantics-driven Design through Geo and Building Information Modelling for Energy-efficient Buildings Integrated in Mixed-use Healthcare Districts	STREAMER	participant	8.000.000	20
2013-09-01	Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock	CULPRIT-SHOCK	participant	5.999.145	17
2013-07-01	GAbapentin in Paediatric Pain	GAPP	participant	5.476.875	15
2013-03-01	Biomarkers of renal graft injuries in kidney allograft recipients	BIOMARGIN	participant	6.000.000	13
2013-02-01	Nanomedicine for target-specific imaging and treatment of atherosclerosis: development and initial clinical feasibility	NANOATHERO	participant	9.833.348	16
2013-01-01	Phase I/II Gene Therapy Trial of Fanconi anemia patients with a new Orphan Drug consisting of a lentiviral vector carrying the FANCA gene: A Coordinated International Action	EUROFANCOLEN	participant	5.380.170	11
2012-12-01	Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)	NET4CGD	participant	5.999.607	11
2012-12-01	A Europe-wide Strategy to enhance Transplantation of highly sensitized patients on basis of Acceptable HLA Mismatches	EUROSTAM	participant	2.623.500	11
2012-11-01	Clinical Development of Nitisinone for Alkaptonuria	DEVELOPAKURE	participant	5.999.999	13
2012-11-01	Metagenomics in Cardiometabolic Diseases	METACARDIS	participant	11.999.992	15
2012-11-01	"Observational Prolonged Trial In Myotonic dystrophy type 1 to Improve QoL-Standards, a Target Identification Collaboration"	OPTIMISTIC	participant	3.000.000	9
2012-10-01	European Consortium for High-Throughput Research in Rare Kidney Diseases	EURENOMICS	participant	11.994.567	28
2012-10-01	Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes	DIABIL-2	coordinator	5.900.000	6
2012-10-01	Clinical European study on the outcome of surgical and hormonal therapy and psychological intervention in disorders of sex development (DSD)	DSD-LIFE	participant	2.999.956	16
2012-07-01	Rapid Identification of Respiratory Tract Infections	RID-RTI	participant	5.997.737	6
2012-03-01	European Consortium for the Early Treatment of Diabetic Retinopathy	EUROCONDOR	participant	5.998.762	18
2012-01-01	IMmune MOdulating strategies for treatment of MErkel cell Carcinoma	IMMOMEC	participant	5.717.979	11
2011-11-01	The effect of intracoronary reinfusion of bone marrow-derived mononuclear cells (BM-MNC) on all-cause mortality in acute myocardial infarction	BAMI	participant	5.993.083	22
2011-10-01	Resistance in Gram-Negative Organisms: Studying Intervention Strategies	R-GNOSIS	participant	11.999.999	24
2011-10-01	Patient-centric model for remote management, treatment and rehabilitation of autistic children	MICHELANGELO	participant	2.871.997	9
2011-10-01	Evolution and Transfer of Antibiotic Resistance	EVOTAR	participant	11.997.392	18
2011-03-01	Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector	GENEGRAFT	participant	4.961.654	10
2011-02-01	IMplementation of quality indicators in PAlliative Care sTudy	IMPACT	participant	2.999.900	13

overview shows latest 50 from 131 projects (2000-01-01 - 2017-12-31)
A full list of projects can be found here: